Susan Bobulsky $ADPT SEC Form 4 Insider Trading

Susan Bobulsky has filed a total of 8 insider trades in $ADPT since 2021. Their most recent trade was a sale of 487 shares, made on Jul 01, 2026. Their largest trade was a sale of 41,338 shares, made on Mar 11, 2026. We estimate that they now own 406,775 shares of $ADPT, worth an estimated $9.1 million.

Insider Trading at $ADPT

There have been a total of 270 insider trades reported at $ADPT since 2021, with 0 shares purchased and 7.4 million shares sold. The most active insider traders in $ADPT stock have been Julie Rubinstein, Harlan S Robins, and Chad M Robins. The most recent trade was a sale of 44,838 shares reported by FRANCIS LO (Chief People Officer), made on Jul 02, 2026.

$ADPT Executives and Stock Owners with Insider Trades

• Julie Rubinstein, President and COO

• Harlan S Robins, Chief Scientific Officer

• Chad M Robins, CEO and Chairman

• R Mark Adams, Chief Operating Officer

• Francis Lo, Chief People Officer

• Chad M Cohen, Chief Financial Officer

• Stacy L Taylor, SVP and General Counsel

• Kyle Piskel, Chief Financial Officer

• Sharon Benzeno, Chief Commercial Ofc Imm Med

• Susan Bobulsky, Chief Commercial Officer, MRD

• Kyle Piskel, Principal Accounting Officer

• Nitin Sood, Chief Commercial Officer, MRD

• Tycho Peterson, Chief Financial Officer

• Julie Rubinstein, President

• Jyoti Palaniappan, SVP, Diagnostics, T-Detect

• Lance Baldo, Chief Medical Officer

• Sharon Benzeno, Chief Business Development Off

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.